{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:55:20Z","timestamp":1791212120703,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016M3A9B5942352"],"award-info":[{"award-number":["2016M3A9B5942352"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002380","name":"Research Fund of Hanyang University","doi-asserted-by":"publisher","award":["HY-2011-G-201100000001880"],"award-info":[{"award-number":["HY-2011-G-201100000001880"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.canlet.2019.05.033","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:01:33Z","timestamp":1559077293000},"page":"15-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT"],"prefix":"10.1016","volume":"459","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinWoo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Kyeong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eonju","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-4531","authenticated-orcid":false,"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.05.033_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/13651820701883148","article-title":"Analysis of mortality rates for pancreatic cancer across the world","volume":"10","author":"Hariharan","year":"2008","journal-title":"HPB"},{"key":"10.1016\/j.canlet.2019.05.033_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.05.033_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12029-009-9082-y","article-title":"Cumulative morbidity and late mortality in long-term survivors of exocrine pancreas cancer","volume":"40","author":"Jacobs","year":"2009","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.canlet.2019.05.033_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.canlet.2019.05.033_bib5","doi-asserted-by":"crossref","first-page":"9510","DOI":"10.1158\/0008-5472.CAN-05-0989","article-title":"In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant","volume":"65","author":"Bergman","year":"2005","journal-title":"Cancer Res."},{"issue":"Suppl 5","key":"10.1016\/j.canlet.2019.05.033_bib6","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2019.05.033_bib7","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.05.033_bib8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.05.033_bib9","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.05.033_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ctrv.2008.11.007","article-title":"Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy","volume":"35","author":"Rivera","year":"2009","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2019.05.033_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1586\/era.10.21","article-title":"Evolution of systemic therapy for advanced pancreatic cancer","volume":"10","author":"Renouf","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib12","series-title":"Tumor-Stroma Interaction of Human Pancreatic Cancer Acquired Resistance to Anticancer Drugs and Proliferation Regulation Is Dependent on Extracellular MatrixProteins.Pdf>","author":"Miyamoto","year":"2004"},{"key":"10.1016\/j.canlet.2019.05.033_bib13","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1371\/journal.pone.0001155","article-title":"Common activation of canonical Wnt signaling in pancreatic adenocarcinoma","volume":"2","author":"Pasca di Magliano","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.05.033_bib14","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1007\/s13277-013-1511-7","article-title":"Collagen as a double-edged sword in tumor progression","volume":"35","author":"Fang","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.canlet.2019.05.033_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/104303403321467199","article-title":"Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points","volume":"14","author":"Sauthoff","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fonc.2013.00193","article-title":"Strategies to increase drug penetration in solid tumors","volume":"3","author":"Choi","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2019.05.033_bib17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1039\/C3MB70431A","article-title":"Extracellular matrix density promotes EMT by weakening cell-cell adhesions","volume":"10","author":"Kumar","year":"2014","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.canlet.2019.05.033_bib18","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.033_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature03100","article-title":"Tissue repair and stem cell renewal in carcinogenesis","volume":"432","author":"Beachy","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.033_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj2230587","article-title":"Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon","volume":"223","author":"Vogel","year":"1984","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2019.05.033_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/346281a0","article-title":"Negative regulation of transforming growth factor-beta by the proteoglycan decorin","volume":"346","author":"Yamaguchi","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2019.05.033_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/gt.2009.142","article-title":"Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy","volume":"17","author":"Choi","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib23","article-title":"A novel sLRP6E1E2 inhibits canonical Wnt signaling, epithelial-to-mesenchymal transition, and induces mitochondria-dependent apoptosis in lung cancer","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.05.033_bib24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jconrel.2015.10.015","article-title":"Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model","volume":"220","author":"Na","year":"2015","journal-title":"J. Control. Release : Off. J. Control. Release Soc."},{"key":"10.1016\/j.canlet.2019.05.033_bib25","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/104303403769211637","article-title":"Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner","volume":"14","author":"Kim","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/hum.2006.167","article-title":"E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects","volume":"18","author":"Kim","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.cgt.7700769","article-title":"ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis","volume":"12","author":"Yun","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib28","first-page":"97","article-title":"Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method","volume":"6","author":"Zhang","year":"2015","journal-title":"Am. J. Canc. Res."},{"key":"10.1016\/j.canlet.2019.05.033_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/156800907780058862","article-title":"From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development","volume":"7","author":"Crompton","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2019.05.033_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","article-title":"Clinical trials with oncolytic adenovirus in China","volume":"7","author":"Yu","year":"2007","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2019.05.033_bib31","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2174\/138920112800958760","article-title":"Clinical development of oncolytic viruses in China","volume":"13","author":"Liang","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.canlet.2019.05.033_bib32","article-title":"Bioluminescent orthotopic model of pancreatic cancer progression","volume":"76","author":"Chai","year":"2013","journal-title":"J. Vis. Exp. JoVE"},{"key":"10.1016\/j.canlet.2019.05.033_bib33","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1158\/1078-0432.CCR-14-2316","article-title":"A novel CDC25B promoter-based oncolytic adenovirus inhibited growth of orthotopic human pancreatic tumors in different preclinical models","volume":"21","author":"Weber","year":"2015","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Canc. Res."},{"key":"10.1016\/j.canlet.2019.05.033_bib34","first-page":"57","article-title":"Serological diagnosis of liver metastasis in patients with breast cancer","volume":"9","author":"Cao","year":"2012","journal-title":"Canc. Biol. Med."},{"key":"10.1016\/j.canlet.2019.05.033_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ymthe.2003.12.008","article-title":"A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases","volume":"9","author":"Sova","year":"2004","journal-title":"Mol. Ther. : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib36","doi-asserted-by":"crossref","first-page":"re8","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2019.05.033_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.immuni.2006.12.007","article-title":"Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration","volume":"26","author":"Wu","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2019.05.033_bib38","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer","volume":"69","author":"Arumugam","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.033_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.cgt.7700494","article-title":"Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy","volume":"9","author":"Kim","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib40","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/JTO.0b013e3182725fa4","article-title":"E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agents","volume":"7","author":"Yamanaka","year":"2012","journal-title":"J. Thorac. Oncol. : Off. Publ. Int. Assoc. Study Lung Canc."},{"key":"10.1016\/j.canlet.2019.05.033_bib41","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jgm.1326","article-title":"E1B 55-kDa deleted, Ad5\/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies","volume":"11","author":"Wang","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.canlet.2019.05.033_bib42","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.3892\/ol.2017.6007","article-title":"A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells in vitro","volume":"13","author":"Liang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2019.05.033_bib43","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1128\/JVI.01972-08","article-title":"E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus","volume":"83","author":"Thomas","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2019.05.033_bib44","first-page":"2666","article-title":"Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53","volume":"60","author":"Dix","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.033_bib45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3349\/ymj.2008.49.5.811","article-title":"Imaging of viral thymidine kinase gene expression by replicating oncolytic adenovirus and prediction of therapeutic efficacy","volume":"49","author":"Kim","year":"2008","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.canlet.2019.05.033_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2016.06.009","article-title":"Recent advances in oncolytic adenovirus therapies for cancer","volume":"21","author":"Rosewell Shaw","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.canlet.2019.05.033_bib47","first-page":"5846","article-title":"Shaping the tumor stroma and sparking immune activation by CD40 and 4-1BB signaling induced by an","volume":"23","author":"Eriksson","year":"2017","journal-title":"Armed Oncolytic Virus"},{"key":"10.1016\/j.canlet.2019.05.033_bib48","series-title":"Phase I Study with ONCOS-102 for the Treatment of Solid Tumors \u2013 an Evaluation of Clinical Response and Exploratory Analyses of Immune Markers","author":"Ranki","year":"2016"},{"key":"10.1016\/j.canlet.2019.05.033_bib49","first-page":"1406","article-title":"Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase","volume":"21","author":"Rodr\u00edguez-Garc\u00eda","year":"2015","journal-title":"Expression"},{"key":"10.1016\/j.canlet.2019.05.033_bib50","first-page":"1419","article-title":"Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang","year":"2018"},{"key":"10.1016\/j.canlet.2019.05.033_bib51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/1535-7163.MCT-17-0671","article-title":"The novel oncolytic adenoviral mutant Ad5-3Delta-A20T retargeted to alphavbeta6 integrins efficiently eliminates pancreatic cancer cells","volume":"17","author":"Man","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/gt.2016.80","article-title":"Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment","volume":"24","author":"Eriksson","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2019.05.033_bib53","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/1078-0432.CCR-14-2213","article-title":"Safety and efficacy of VCN-01, an oncolytic adenovirus combining fiber HSG-binding domain replacement with RGD and hyaluronidase expression","volume":"21","author":"Rodriguez-Garcia","year":"2015","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Canc. Res."},{"key":"10.1016\/j.canlet.2019.05.033_bib54","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.3748\/wjg.v16.i32.4084","article-title":"Serological diagnostic factors for liver metastasis in patients with colorectal cancer","volume":"16","author":"Wu","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2019.05.033_bib55","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1371\/journal.pone.0001155","article-title":"Common activation of canonical Wnt signaling in pancreatic adenocarcinoma","volume":"2","author":"di Magliano","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.05.033_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2009.01.018","article-title":"Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and \u03b2-catenin stabilization","volume":"15","author":"Wang","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2019.05.033_bib57","doi-asserted-by":"crossref","first-page":"17649","DOI":"10.1074\/jbc.M111.229427","article-title":"Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels","volume":"286","author":"Ingraham","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.05.033_bib58","first-page":"1306","article-title":"Association of matrix metalloproteinase-9 and decorin expression with the infiltration of cervical cancer","volume":"17","author":"Tanaka","year":"2019","journal-title":"Oncol. Lett."},{"issue":"Pt 3","key":"10.1016\/j.canlet.2019.05.033_bib59","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3220809","article-title":"Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release","volume":"322","author":"Imai","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2019.05.033_bib60","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1074\/jbc.274.8.4489","article-title":"Decorin is a biological ligand for the epidermal growth factor receptor","volume":"274","author":"Iozzo","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.05.033_bib61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-beta-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2019.05.033_bib62","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/CCO.0b013e32835b6371","article-title":"TGF-beta signaling and epithelial-mesenchymal transition in cancer progression","volume":"25","author":"Katsuno","year":"2013","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.canlet.2019.05.033_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/IJGC:29:1:01","article-title":"Adjuvant and neoadjuvant therapies of pancreatic cancer: a review","volume":"29","author":"Harris","year":"2001","journal-title":"Int. J. Pancreatol. : Off. J. Int. Assoc. Pancreatol."},{"key":"10.1016\/j.canlet.2019.05.033_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2019.05.033_bib65","first-page":"583","article-title":"Drug penetration in solid tumours, Nature reviews","volume":"6","author":"Minchinton","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2019.05.033_bib66","first-page":"27","article-title":"Pancreatic cancer: understanding and overcoming chemoresistance, Nature reviews","volume":"8","author":"Wang","year":"2011","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2019.05.033_bib67","first-page":"75","article-title":"Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic","volume":"1796","author":"Voulgari","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2019.05.033_bib68","doi-asserted-by":"crossref","first-page":"32739","DOI":"10.1074\/jbc.272.52.32739","article-title":"Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis","volume":"272","author":"Shao","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.05.033_bib69","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","article-title":"p53-dependent apoptosis modulates the cytotoxicity of anticancer agents","volume":"74","author":"Lowe","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.05.033_bib70","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1593\/neo.09760","article-title":"Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways","volume":"11","author":"Hu","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2019.05.033_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(02)03262-3","article-title":"CD44 signaling through focal adhesion kinase and its anti-apoptotic effect","volume":"528","author":"Fujita","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2019.05.033_bib72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/1568009043333032","article-title":"The Akt pathway: molecular targets for anti-cancer drug development","volume":"4","author":"Mitsiades","year":"2004","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.canlet.2019.05.033_bib73","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure - an obstacle in cancer therapy","volume":"4","author":"Heldin","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2019.05.033_bib74","series-title":"Desmoplasia and Chemoresistance in Pancreatic Cancer","author":"Whatcott","year":"2012"},{"key":"10.1016\/j.canlet.2019.05.033_bib75","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-10-1855","article-title":"Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2","volume":"71","author":"Dangi-Garimella","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.033_bib76","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/09553000701570204","article-title":"Extracellular matrix regulation of drug resistance in small-cell lung cancer","volume":"83","author":"Hodkinson","year":"2007","journal-title":"Int. J. Radiat. Biol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T08:43:22Z","timestamp":1569055402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519303283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":76,"alternative-id":["S0304383519303283"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.033","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}